| Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1261 | 2021 |
| Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 LM Haile, K Kamenov, PS Briant, AU Orji, JD Steinmetz, A Abdoli, ... The Lancet 397 (10278), 996-1009, 2021 | 546 | 2021 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 GBDAR Collaborators The Lancet, 2022 | 540 | 2022 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 445 | 2021 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … GBDUM Collaborators The Lancet, 2021 | 306 | 2021 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 222 | 2022 |
| Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease … GBDLBP Collaborators The Lancet Rheumatology 5 (6), E316-E329, 2023 | 188 | 2023 |
| Curcumin in combination with anti-cancer drugs: A nanomedicine review H Batra, S Pawar, D Bahl Pharmacological Research 139, 91-105, 2019 | 142 | 2019 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 GBDHFC Network The Lancet Global Health, 2023 | 120 | 2023 |
| Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 NC Galles, PY Liu, RL Updike, N Fullman, J Nguyen, S Rolfe, AN Sbarra, ... The Lancet 398 (10299), 503-521, 2021 | 118 | 2021 |
| Fatal police violence by race and state in the USA, 1980–2019: a network meta-regression GBD 2019 Police Violence US Subnational Collaborators The Lancet 398 (10307), 1239-1255, 2021 | 116 | 2021 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 201 GBDLRI Collaborators Lancet Infectious Diseases, 2022 | 100 | 2022 |
| KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries S Pawar, S Donthamsetty, V Pannu, P Rida, A Ogden, N Bowen, R Osan, ... Journal of ovarian research 7, 1-9, 2014 | 99 | 2014 |
| Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 … AE Micah, IE Cogswell, B Cunningham, S Ezoe, AC Harle, ER Maddison, ... The Lancet 398 (10308), 1317-1343, 2021 | 92 | 2021 |
| Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 GBDO Collaborators The Lancet Rheumatology, 2023 | 88 | 2023 |
| Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems Local Burden of Disease HIV Collaborators ladwyer@ uw. edu Bmc Medicine 19, 1-25, 2021 | 86 | 2021 |
| Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 GBDSCD Collaborators The Lancet Haematology, 2023 | 81 | 2023 |
| Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 JR Ledesma, J Ma, A Vongpradith, ER Maddison, A Novotney, MH Biehl, ... The lancet infectious diseases 22 (2), 222-241, 2022 | 81 | 2022 |
| Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 GBDHIV Collaborator The Lancet HIV, 2021 | 76 | 2021 |
| The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of … GBDBPH Collaborators The Lancet Health Longevity, 2022 | 64 | 2022 |
Chandrajit LahiriProfessor, Dept. of Biotechnology, Atmiya UniversityVerified email at atmiyauni.ac.in
